PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.69%
Revenue growth under 50% of 2127.T's 29.85%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.43%
Gross profit growth under 50% of 2127.T's 32.14%. Michael Burry would be concerned about a severe competitive disadvantage.
10.35%
EBIT growth below 50% of 2127.T's 27.27%. Michael Burry would suspect deeper competitive or cost structure issues.
2.77%
Operating income growth under 50% of 2127.T's 37.70%. Michael Burry would be concerned about deeper cost or sales issues.
10.77%
Net income growth at 50-75% of 2127.T's 19.58%. Martin Whitman would question fundamental disadvantages in expenses or demand.
10.76%
EPS growth at 50-75% of 2127.T's 19.54%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
10.76%
Diluted EPS growth at 50-75% of 2127.T's 19.54%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.00%
10Y revenue/share CAGR under 50% of 2127.T's 566.34%. Michael Burry would suspect a lasting competitive disadvantage.
-4.42%
Negative 5Y CAGR while 2127.T stands at 185.70%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-31.64%
Negative 3Y CAGR while 2127.T stands at 108.61%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
10Y OCF/share CAGR in line with 2127.T's 100.00%. Walter Schloss would see both as similarly efficient over the decade.
100.00%
Positive OCF/share growth while 2127.T is negative. John Neff might see a comparative advantage in operational cash viability.
No Data
No Data available this quarter, please select a different quarter.
128.06%
Below 50% of 2127.T's 1872.50%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
16.10%
Below 50% of 2127.T's 207.04%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-24.32%
Negative 3Y CAGR while 2127.T is 100.80%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
93.99%
Below 50% of 2127.T's 267.51%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
30.55%
Below 50% of 2127.T's 182.90%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-14.41%
Negative 3Y equity/share growth while 2127.T is at 100.23%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.45%
Firm’s AR is declining while 2127.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.50%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.38%
Negative asset growth while 2127.T invests at 4.20%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.50%
50-75% of 2127.T's 4.83%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-0.73%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
1.10%
SG&A declining or stable vs. 2127.T's 15.88%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.